Eliminating incontinence in women

IncontiLase^® is a patented, non-invasive Er:YAG laser procedure for the treatment of mild and moderate stress urinary incontinence. It is based on non-ablative photothermal stimulation of vaginal tissue. This leads to the formation of new collagen fibres, shrinkage and firming of the vaginal mucosa and collagen-rich endopelvic fascia, resulting in greater support for the bladder.

The IncontiLase^® procedure can treat mild to moderate stress and mixed urinary incontinence. Clinical research shows that it is an effective, simple and safe procedure.

How does it work IncontiLase^® ?

• The photonic non-ablative Er:YAG laser with a wavelength of 2,940 nm and SMOOTH mode thermally acts on the vaginal tissue, stimulating the remodelling of existing collagen and the synthesis of new collagen fibres in the area of the vestibule and urethra, as well as along the anterior wall of the vagina.
• The end result of the new collagen formation is a shrinking and firming of the vaginal mucosa and collagen-rich endopelvic fascia, resulting in increased support for the bladder and restoration of normal continence.

The unique benefits of IncontiLase laser treatment^®for you

The main advantages of laser treatment with IncontiLase^® are that the procedure does not require surgical incisions or stitches, as the procedure is not accompanied by bleeding. The procedure is virtually painless and the recovery is extremely fast, with no need for analgesics or antibiotics.

Two to three treatments are recommended to effectively relieve the symptoms of mild to moderate stress urinary incontinence. No special preparation for or follow-up to the intervention is required. Patients can immediately return to normal daily activities.

Research confirms that laser treatment with IncontiLase^® is effective and safe for relieving symptoms of mild and moderate urinary incontinence.

Reliable clinical results

Scientific results from clinical research show excellent improvement in symptoms of mild and moderate stress urinary incontinence.

• Almost 70% of patients are dry after 120 days.
• At 120 days after the IncontiLase^® procedure, 94% of patients reported improvement and 68% of all patients said they no longer had symptoms of urinary incontinence.
• Improvements in incontinence symptoms were measured in all parameters.
• No serious side effects have been reported in any of the studies.